Overview

Breonics, Inc. is a biomedical research and development company headquartered in Otisville Technology Park, Orange County, New York. BREONICS' focus is to apply its novel bioengineering technologies to create innovative medical products for the clinical organ transplant and tissue replacement markets. The Company's primary strategy is to capitalize on its technologies by developing them to product definition and to then collaborate with a strategic partner who has the expertise and resources for rapid commercial introduction.

For more general information about Breonics, click here.

Exsanguinous Metabolic Support

EMS is BREONICS core technology and consists of the solutions and equipment designed to maintain an organ, or a block of vascularized anatomy, off-line from the rest of the physiologic system. EMS is a break-through technology that provides a number of unique medical applications the first of which will be to provide more human organs for clinical transplantation.

For expanded information about EMS for clinical transplantation, click here.